Search
953 results found
IAM | USA | 12 Feb 2020
How cannabis companies are using cross-industry innovation to solve their R&D issues
In a previous article, we discussed how patent data can help R&D teams to gain significant insight into parallel industries, which they can use to
IAM | USA | 12 Feb 2020
Tech tools to draft patent applications could revolutionise IP proceedings
Highly skilled patent professionals carry out the predominantly manual task of drafting a patent application, which involves the use of set phrases
IAM | Australia | 12 Feb 2020
Who is leading the AI chips IP race? Best practice in IP management
AI and its diverse applications (eg, machine learning and deep learning) have seen significant market growth in the past decade and are on the cusp
IAM | European Union | 12 Feb 2020
Takeda case study clarifies extensions to patent protection for pharmaceutical products
In many jurisdictions, the statutory term for patent protection can be extended under certain circumstances in order to compensate for time lost due
IAM | USA | 12 Feb 2020
The future of 5G patent licensing
Most industry experts predict that licensing 5G patents will be more complex than in earlier generations such as 3G or 4G
IAM | Russia, Eurasia | 12 Feb 2020
Unity of invention requirements: Russia versus Eurasia
According to Russian and Eurasian patent regulations, an application must relate to one invention or a group of inventions. In the latter case, all
IAM | China | 12 Feb 2020
Trademark squatters get smarter in China - a look at the latest tactics
Trademark squatting has been a constant concern for foreign companies trying to enter the Chinese market
IAM | USA, European Union | 10 Feb 2020
The six big ways the US and Europe differ on software patents
The USPTO and EPO do not see software-related inventions in the same way. NLO attorneys Marta Alvarez Guede and Katelyn Bernier highlight what
IAM | USA, China | 8 Feb 2020
The inconvenient truth is that the West gifted China its 5G leadership
The Trump administration finally seems to have woken up to the fact that for some inexplicable reason the West has allowed the Chinese to gain a
IAM | United Kingdom, European Union | 6 Feb 2020
Key takeaways from IAM’s 2020 Pharma and Biotech IP event
Last week, leading life sciences IP professionals from around the world gathered at The Bloomsbury in London for IAM’s fourth annual Pharma and
